These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4389181)

  • 1. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH.
    Gigon PL; Gram TE; Gillette JR
    Biochem Biophys Res Commun; 1968 May; 31(4):558-62. PubMed ID: 4385338
    [No Abstract]   [Full Text] [Related]  

  • 4. Spectral studies of drug interaction with hepatic microsomal cytochrome.
    Schenkman JB; Remmer H; Estabrook RW
    Mol Pharmacol; 1967 Mar; 3(2):113-23. PubMed ID: 4382749
    [No Abstract]   [Full Text] [Related]  

  • 5. An approach measurement of the stoichiometric relationship between hepatic microsomal drug metabolism and the oxidation of reduced nicotinamide adenine dinucleotide phosphate.
    Stripp B; Zampaglione N; Hamrick M; Gillette JR
    Mol Pharmacol; 1972 Mar; 8(2):189-96. PubMed ID: 4402003
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c (P-450) reductase in drug oxidation.
    Glazer RI; Schenkman JB; Sartorelli AC
    Mol Pharmacol; 1971 Nov; 7(6):683-8. PubMed ID: 4402120
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of drug metabolism. II. Qualitative differences in the microsomal N-demethylating systems stimulated by polycyclic hydrocarbons and by phenobarbital.
    Sladek NE; Mannering GJ
    Mol Pharmacol; 1969 Mar; 5(2):186-99. PubMed ID: 5787085
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE; Guarino AM; Schroeder DH; Davis DC; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):12-21. PubMed ID: 5471443
    [No Abstract]   [Full Text] [Related]  

  • 9. Microsomal epoxidation of aldrin in lepidopterous larvae.
    Williamson RL; Schechter MS
    Biochem Pharmacol; 1970 May; 19(5):1719-27. PubMed ID: 4398018
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 11. The incomplete conversion of hepatic cytochrome P-450 to P-420 by mercurials.
    Franklin MR
    Mol Pharmacol; 1972 Nov; 8(6):711-21. PubMed ID: 4344998
    [No Abstract]   [Full Text] [Related]  

  • 12. Demethylation studies. VI. The inhibition of hepatic microsomal oxygenation by 2,4-dichloro(6-phenylphenoxy)ethylamine and related compounds.
    McMahon RE; Mills J; Culp HW; Gibson WR; Miller WM; Marshall FJ
    J Med Chem; 1969 Mar; 12(2):207-11. PubMed ID: 5783590
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
    Netter KJ; Illing HP
    Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
    [No Abstract]   [Full Text] [Related]  

  • 15. The interactions of inducers, inhibitors, and substrates of drug-metabolizing enzymes with rat liver cytochrome P-450.
    Soliman MR; Johnson HD; Wade AE
    Drug Metab Dispos; 1974; 2(1):87-96. PubMed ID: 4150140
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of tertiary amine N-oxides by liver microsomal cytochrome P-450.
    Sugiura M; Iwasaki K; Kato R
    Mol Pharmacol; 1976 Mar; 12(2):322-34. PubMed ID: 4725
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. VIII. Different catalytic activities of rabbit and rat cytochromes P-448.
    Kawalek JC; Lu AY
    Mol Pharmacol; 1975 Mar; 11(2):201-10. PubMed ID: 235734
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug metabolism by hepatic microsomes from phenobarbital-treated or starved male and female rats in the presence of inhibitors.
    Gigon PL; Bickel MH
    Life Sci II; 1971 Feb; 10(3):163-73. PubMed ID: 4252538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.